If you need more lookups,
subscriptions start at $34 USD/month.
Emma Bosch Location
Barcelona, CT, ES
Emma Bosch Work
2024 -now Director Global Regulatory Strategy @
2022 -2024 Associate Director Global Regulatory Affairs Development Strategy @
2021 -2022 Associate Director Regulatory Affairs @
2011 -2021 Regulatory Affairs Manager @
2010 -2011 Regulatory Strategy Officer @
2009 -2009 Regulatory Affairs Officer @
2007 -2008 Chemist @
Emma Bosch Education
Sagardoy School
IMPACTO (leadership development program, Organizational Leadership)
2025-2025
Universitat de Barcelona
M.Sc (Organic Chemistry)
2006-2007
Universitat de Barcelona
B.Sc (Chemistry)
2001-2006
Emma Bosch Skills
Regulatory Affairs
Clinical Trials
Pharmaceutical Industry
Biopharmaceuticals
Gene Therapy
FDA
Product Development
IND
Biotechnology
CMC
Regulatory Strategy
Chemistry
Medical Writing
Drug Discovery
Project Management
Clinical Development
GLP
GMP
Validation
Sop
Strategy
Clinical Research
Genetically Modified Organisms
Drug Development
Life Sciences
R&D
Regulatory Submissions
Oncology
Research and Development (R&D)
Regulatory
Research and Development R&d
EMA
Research and Development
Advanced Therapies
Atmps
Orphan Drugs
Common Technical Document
Environmental Risk
Regulatory Documentation
Technical Documentation
Regulatory Compliance
Biosafety
Odd
Briefing Documents
Scientific Advice
Clinical Trial Applications
Emma Bosch Summary
Emma Bosch, based in Barcelona, CT, ES, is currently a Director Global Regulatory Strategy at Alexion Pharmaceuticals, Inc.. Emma Bosch brings experience from previous roles at Alexion Pharmaceuticals, Inc., PharmaMar, VCN Biosciences S.L. and Grupo Ferrer Internacional. Emma Bosch holds a 2025 - 2025 IMPACTO in leadership development program, Organizational Leadership @ Sagardoy School. With a robust skill set that includes Regulatory Affairs, Clinical Trials, Pharmaceutical Industry, Biopharmaceuticals, Gene Therapy and more. Emma Bosch has 2 emails on RocketReach.
Looking for a different Emma Bosch?
Find contact details for 700 million professionals.